Penumbra, Inc. (PEN)
336.42
+0.15
(+0.04%)
USD |
NYSE |
Mar 26, 16:00
336.23
-0.19
(-0.06%)
Pre-Market: 07:08
Penumbra Free Cash Flow : 174.93M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.658B |
| Revvity, Inc. | 506.94M |
| Abbott Laboratories | 7.395B |
| Alphatec Holdings, Inc. | -4.41M |
| Artivion, Inc. | 0.839M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 86.48M |
| Cash from Investing (Quarterly) | -225.65M |
| Cash from Financing (Quarterly) | 5.057M |
| Free Cash Flow Per Share (Quarterly) | 1.728 |
| Free Cash Flow to Equity (Quarterly) | 65.40M |
| Free Cash Flow to Firm (Quarterly) | 68.30M |
| Free Cash Flow Yield | 1.32% |